A slower-than-usual year for medtech M&A in 2023 was reflected in relatively few company exits from the Top 100 annual listing of publicly traded device, diagnostics and healthtech companies by revenues.
Medtech Industry Reaches New Chapter In Its Structural Evolution
Big Ticket M&A Sporadically Eye-Catching In 2023-24
The Top 100 ranking of global medtechs by revenues for 2023 illustrated how the leaders continue to tailor innovation to users and patients according to market trends while driving portfolio management for growth.
